Home Insider News Insider Alert: Novavax Inc. 's EVP, CMO, CBO, Trizzino John, Makes A...

Insider Alert: Novavax Inc. [NVAX]’s EVP, CMO, CBO, Trizzino John, Makes A $2,012,353 Sell

On Jan. 05, Trizzino John divested U.S. $2,012,353 in shares of Novavax Inc.. The EVP, CMO, CBO sold 17,913 shares at a price per share of $112.34. The transaction decreased this specific insider’s holdings to 287 shares worth around $36787.66 at present.

Jefferies launched its Novavax Inc. [NVAX] rating to the equivalent of a Buy and assigned the price target of $200, in a research note dated December 14, 2020. That figure represents around a 35.91% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Jefferies’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in mid December. Meanwhile, H.C. Wainwright had maintained its rating on NVAX to the earlier “Buy” rating, in a research note produced for clients August 06, 2020. In addition, there was an upgrade from JP Morgan on August 05, 2020. The rater changed NVAX from “a Neutral” to “an Overweight”.

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Novavax Inc. [NASDAQ:NVAX] a Good Buy Right Now?

It should be noted that NVAX technical indicators for short, intermediate as well as long term progress have placed an overall average of 88% as Buy. The average signal changed from 56% Buy in the last week and compares with 72% Buy in the past month. Data from Novavax Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 3.99 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 4.33 million shares while the medium term average advocated for 50% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 4.55 million shares.

NVAX Price Performance

On Wall Street, Novavax Inc. [NASDAQ:NVAX] finished Thursday’s session up 3.59% at $128.18. The stock went up to $129.95 at the same session while its lowest single day price was $124.03. In the last five days, it saw a rise of about 7.75%, Novavax Inc. shares gained by almost 14.95% since the beginning of the year. However, the share price has dropped to as low as -32.32% below its one year high. On 01/07/21, the company shares recorded $129.95, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $109.01. The company’s shares have inclined by 2894.86% in the past year. The 50-day SMA achieved is $108.04 while the 200-day SMA is $87.78. Volume dropped to 2.92 million from 3.2 million in the previous session.

NVAX Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 124.82 level, and in case of violation of this particular level, it will cause more drop to 121.47 level. On the upper level, 133.31 is still the key resistance. The stock may increase to the subsequent resistance at 130.74. The Relative Strength Index (RSI) pinned on the 14-day chart is 56.97, implying a neutral technical stance while the MACD stands at 1.17, meaning price will increase in the next trading period. Percent R indicator moved to 17.51%, implying bullish price movement. Stochastic %K at 61.14% suggest holding the stock.

What is the short interest in Novavax Inc.?

Short interest in the Novavax Inc. stock has surged, increasing by 1.48 million shares to total 7.23 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 8.71 million, data from Yahoo Finance shows. The decrease of -20.47% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 11.40% of the overall float for the stock.

Novavax Inc.’s Biggest Shareholders: Who Owns Novavax Inc. [NVAX]?

Filings by The Vanguard Group, Inc. showed that the firm now holds a total of 5,307,429 shares or roughly 8.34% of the outstanding NVAX shares. This means their shares have increased by 789,322 from the 5,307,429 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, BlackRock Fund Advisors updated stake is worth $510,722,892. Details in the latest 13F filings reveal that Franklin Advisers, Inc. disposed off their -25.37% stake valued at $313,096,869 while SSgA Funds Management, Inc. cut theirs at $238,385,831. During the last quarter, Franklin Advisers, Inc. liquidated -763,002 of its shares in Novavax Inc. while SSgA Funds Management, Inc. sold -604,488 shares. The RA Capital Management LP’s holdings currently number 1,198,602 shares at $153636804.36. According to the firm’s last 13F report, Capital Research & Management Co shares in the company at filing stood at 1,156,379 shares, roughly $161,314,871.

NVAX Earnings Forecast For The Current Quarter

Novavax Inc. [NVAX] is expected to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $347.92M and an earnings per share of -$1.31 for Dec 2020. Looking further ahead, the company is expected to report revenue of $763.91M at an EPS of $3.04 for Mar 2021. The estimates represent upside of 463.40% and 421.30% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

NVAX Earnings Estimates For The Current Year

For the financial year, Novavax Inc. [NASDAQ:NVAX] is expected to bring in revenue of $543.87M. The returns are nearly $525.21 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at -5.49, higher than that of FY19 by $0.02. Estimates put this year’s earnings growth at 0.40%, 421.30% for the next. As for sales, forecasts are for an increase of 2,814.30% in the current fiscal year and a further 463.40% over the following year.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What are analyst thoughts on Novavax Inc.?

Looking forward to the Novavax Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Novavax Inc. stock at $209.00 within the next 12 months, which represents almost 38.67 per cent growth from its previous closing price of $128.18. The highest analysts’ target for Novavax Inc. stock projections is $223.00 and the lowest one is $75.00. Still, 7 analysts sharing their consensus rating for NVAX stock in 2021 agree that it is an Overweight.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Drove The STRATA Skin Sciences, Inc. (NASDAQ: SSKN) Stock In Extended Trading?

Shares of dermatology-focused company STRATA Skin Sciences, Inc. (NASDAQ: SSKN) leapt 15.03% to $1.99 in the trading after ring of the bell on Monday....

Why Sundial Growers (SNDL) shares have skyrocketed in intraday trading?

Shares of Sundial Growers (SNDL) have been on a skywalk. As of 10:47 AM EST, the seller, and producer of Cannabis products recorded $1.38...

What Caused 35% Pre-Market Surge In electroCore, Inc. (ECOR) Stock Today?

Shares of electroCore, Inc. (ECOR) has been surging strongly in the pre-market session today following an announcement of exclusive distribution agreement in Australia. The...

Zix Corp (ZIXI) Stock Surged 7% After-Hour For What Reason?

The stock of email security solution provider Zix Corp (ZIXI) has added 7.05% to its value in the after-hours trading on Friday. The company...

Apple Inc. (AAPL) Stocks dip but future prospects for the company seem very positive

On Thursday, Apple shares (NASDAQ: AAPL) closed at $120.99 which is 3.5% lower. In the after-hours session, the price further declined by 0.2%.  The...

Why there is an uncertainty around Palantir Technologies Inc (PLTR)?

Palantir Technologies Inc (PLTR)‎ is a public American software company that specializes in big data analytics. The company has shown a recovery in its...

Here’s What You Should Know About Just Energy Group Inc (JE) Stock

Just Energy Group Inc (JE)‎ stock has shown a rise in the last trading session. JE is a natural gas and electricity retailer based...

ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful first trial report

ASLAN Pharmaceuticals (NASDAQ: ASLN) moved upward an impressive 73.58% and has reached a share price of $7.69. ASLAN had previously closed at $4.43. This...

Related News

Insider Selling Report: Nu Skin Enterprises Inc. [NUS]’s Pres, Napierski Ryan S, Sells 4,844 Shares

On Jan. 07, Napierski Ryan S divested U.S. $286,038 in shares of Nu Skin Enterprises Inc.. The Pres sold 4,844 shares at a price...

Insider Alert: Harmonic Inc. [HLIT]’s SVP, Video R, D, Haltmayer Neven, Makes A $117,240 Sell

On Jan. 06, Haltmayer Neven divested U.S. $117,240 in shares of Harmonic Inc.. The SVP, Video R, D sold 15,632 shares at a price...

ACM Research Inc. [ACMR] Sees 2,000 Share Insider Sell From Dir Liu Tracy

On Jan. 06, Liu Tracy divested U.S. $200,000 in shares of ACM Research Inc.. The Dir sold 2,000 shares at a price per share...

Insider Selling: MasTec Inc. [MTZ] CFO Sells 30,027 Shares Worth $2,404,436

On Jan. 07, Pita George divested U.S. $2,404,436 in shares of MasTec Inc.. The CFO sold 30,027 shares at a price per share of...

Cigna Corporation [CI] Insider Just Sold 8,972 Shares. Should You?

On Jan. 06, Miller Steven B divested U.S. $1,884,120 in shares of Cigna Corporation. The EVP, Chief Clinical Officer sold 8,972 shares at a...


Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.